Cardiovascular safety update of tadalafil: retrospective analysis of data from placebo-controlled and open-lable clinical trials of tadalafil with as needed, three times-per-week or once-a -day dosing. [Text] / R. A. Kloner, G. Jackson, A. M. Hutter et al. // AMERICAN JOURNAL of CARDIOLOGY. - 2006. - Vol.97, N12. - P1778-1784. - Ref. : P. 1783-1784. . - ISSN 0002-9149 Рубрики: СЕРДЕЧНО-СОСУДИСТЫЕ БОЛЕЗНИ--CARDIOVASCULAR DISEASES Кл.слова (ненормовані): ТАДАЛАФИЛ Дод.точки доступу: Kloner, R. A.; Jackson, G.; Hutter, A. M.; Mittleman, M. A.; Chan, M. et al. Экз-ры: